SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Elder Pharma targets 20% growth in revenues this fiscal

02 Jan 2012 Evaluate

Elder Pharmaceuticals is looking 20% growth in revenues to around Rs 1,200 crore in the current fiscal on the back of new product launches. The company is targeting to achieve the growth in the domestic market by its existing strong range of branded products including Shelcal, Eldervit and Chymoral as well as further brand building of its new product range.

The Mumbai-based firm, which derives 95% of its revenues from the domestic market, is also expecting a better performance from its in-licensed brands and overseas subsidiaries. Last year, the company had a turnover of about Rs 1,000 crore on a consolidated basis with maximum traction in women's healthcare, wound care and the nutraceutical segments.

At present, the company has 24 in-licence agreements with various firms for the domestic market.

The company has around six manufacturing units in India, all as per international standards. Post increasing its stake in Elder Biomeda AD and Neutrahealth PLC, EPL also has access to the manufacturing units of these companies in Bulgaria and Birmingham, UK respectively coupled with distribution network and brands of the same.

Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×